Dr. Ramon Nebres Roco, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 2799 Orchard Trail Dr, Troy, MI 48098 Phone: 248-642-3585 |
Dr. Bienvenido Basilio Marquez, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 5155 Fedora Dr, Troy, MI 48085 Phone: 248-879-8215 |
Dr. Sangita C. Patel, General Practice Medicare: Accepting Medicare Assignments Practice Location: 2888 E Long Lake Rd Ste 150, Troy, MI 48085 Phone: 248-250-9920 Fax: 248-250-9926 |
News Archive
The Philadelphia Inquirer/Kansas City Star: "Most nurse practitioners still have master's degrees, but nursing schools want the doctor of nursing practice degree to be the entry-level degree for advanced-practice nurses by 2015. Enrollment in those programs nationally jumped from 70 in 2002 to more than 5,000 last year." The titles of nurses and how they interact with academic degrees are causing some confusion among patients and resentment from doctors. "Most newly graduating physical therapists now have doctorates, too.
Consumers often use the length of time a service takes as a measure of its quality. The longer a session lasts, the better the value.
Assessment of patient outcomes allows physicians and researchers to measure the success or failure of diagnostics and treatments that patients receive. One set of measurement tools focuses on assessing adult pain and is included in a special issue of Arthritis Care & Research, a journal of the American College of Rheumatology (ACR), providing physicians and researchers with a single resource of 250 patient outcomes measurements in rheumatology.
Diagnostic Hybrids, a Quidel Company, received approval from the People's Republic of China's State Food and Drug Administration (SFDA) for its D3 Ultra DFA Respiratory Virus Screening and ID Kit. The D3 Ultra DFA Respiratory Virus Screening and ID Kit is a direct fluorescence assay (DFA) that provides rapid, sensitive and specific screening and identification of Influenza A, Influenza B, Parainfluenza 1, 2, & 3, Respiratory Syncytial Virus and Adenovirus.
WuXi PharmaTech, a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced it has reached an agreement with Johnson & Johnson Pharmaceutical Research & Development, a division of Janssen Pharmaceutica N.V. (JANSSEN), to collaborate in the area of preclinical services.
› Verified 4 days ago